Molecular Templates, Inc. ("MTEM"), a clinical stage biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies that possess unique mechanisms of ...
AUSTIN, Texas, June 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates (MTEM), Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery ...
AUSTIN, Texas, April 07, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), today announced that the U.S. Food and Drug Administration (the “FDA”) ...
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates (MTEM), Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery ...
AUSTIN, Texas, June 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果